Data Sheet 2_Circulating prostaglandin E2 concentrations decrease at birth in premature lambs.docx by Timothy J. R. Panneflek (22702136)

CD5-CK2 Signaling Modulates Erk Activation and Thymocyte Survival by Carlos A. Mier-Aguilar (3605360)

“…Using a gene-targeted mouse in which the CD5-CK2BD is selectively ablated (CD5-ΔCK2BD), we determined that loss of function of CD5-CK2 signaling in a MHC-II selecting TCR transgenic (OT-II) mouse resulted in decrease in double positive (DP) thymocytes, which correlated with enhanced apoptosis. …”

Presentation3_Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity.pdf by Ying Wang (11406)

Image1_Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity.pdf by Ying Wang (11406)

Presentation2_Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity.pdf by Ying Wang (11406)

Presentation1_Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity.pdf by Ying Wang (11406)

The effect of investigated leucettines on the level of DYRK1A in MIN6 cells. by Barbara Pucelik (2988795)

Image1_Restricting Glutamine Uptake Enhances NSCLC Sensitivity to Third-Generation EGFR-TKI Almonertinib.TIF by Yaming Liu (4908724)

“…The combination of SLC1A5 inhibitor V9302 and Almonertinib had a synergistic inhibitory effect on the proliferation of NSCLC. …”

Critical Membrane Concentration and Mass-Balance Model to Identify Baseline Cytotoxicity of Hydrophobic and Ionizable Organic Chemicals in Mammalian Cell Lines by Jungeun Lee (142511)

“…However, their applicability is limited to hydrophilic neutral compounds. To develop a prediction model that includes more hydrophobic and charged organic chemicals, a mass balance model was applied for mammalian cells (AREc32, AhR-CALUX, PPARγ-BLA, and SH-SY5Y) considering different bioassay conditions. …”

Rest episodes during the DP of W flies. by Anastasia M. Terzidou (14659896)

Kinetics of bee venom specific antibodies. by Andreas Hartmann (241073)

Ab Initio Study of the Substituent Effects on the Relative Stability of the <i>E</i> and <i>Z</i> Conformers of Phenyl Esters. Stereoelectronic Effects on the Reactivity of the Car... by Helmi Neuvonen (2643793)

“…ED/EW substituents adjust the availability of the π*_C__O antibonding orbital to interact with the lone pair orbital of the attacking nucleophile and therefore affect the reactivity:  EW substituents increase and ED substituents decrease it. Excellent correlations were observed between the rate coefficients of nucleophilic acyl substitutions and π*_C__O occupancies of the ester series <b>4 </b>and <b>5</b>.…”

Maternal exposure to U-46619 decreases fetal body weight at E19 compared to sham pups. by Camille M. Fung (844334)

“…<p>Pregnant mice were exposed to a TXA₂- analog (U-46619) or vehicle via micro-osmotic pump infusion from E12.5 until birth (term ~20 days). …”

Three New Phases in the K/Cu/Th/S System:  KCuThS₃, K₂Cu₂ThS₄, and K₃Cu₃Th₂S₇ by Hugh D. Selby (2038372)

“…All three phases are semiconductors with optical band gaps of 2.95, 2.17, and 2.49 eV(<b>I</b>−<b>III</b>). Compound <b>I</b> crystallizes in the orthorhombic space group <i>Cmcm</i> with <i>a </i>= 4.076(1) Å, <i>b</i> = 13.864(4) Å, and <i>c</i> = 10.541(3) Å. …”

Rest episodes during the LP of W flies. by Anastasia M. Terzidou (14659896)

Comparison of rest episodes between W and AR virgin male flies. by Anastasia M. Terzidou (14659896)

Replacing i3 of Rs1 with that of 5-HT_1A results in a receptor, Rs1-i3-5-HT_1A, with weak G_isignaling. by Wei Chun Chang (43479)

“…<p>(A) Rs1-i3-5-HT_1A chimera decreased cAMP accumulation. …”

Advancing the science of NOWS research. by Sarah E. Maylott (14560785)

“…Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. …”

Protocol measures. by Sarah E. Maylott (14560785)

“…Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. …”

Cry variables. by Sarah E. Maylott (14560785)

“…Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. …”